Last update 23 Jan 2025

HCK x BTK C481S

Basic Info

Related Targets
HCKBTK C481S

Related

1
Drugs associated with HCK x BTK C481S
KIN-8194
Target
BTK C481S x HCK
Mechanism
BTK C481S inhibitors [+1]
Active Org.
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
Originator Org.
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
Active Indication
Lymphoma [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with HCK x BTK C481S
Login to view more data
100 Translational Medicine associated with HCK x BTK C481S
Login to view more data
0 Patents (Medical) associated with HCK x BTK C481S
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free